Pilot Study in the Cholesterol Absorption Reduction After Consumption of Low-fat, Drinkable Fermented Milk Enriched With Plant Sterols
Not Applicable
Completed
- Conditions
- Mildly Hypercholesterolemic Subjects
- Interventions
- Other: 2- Low fat drinkable fermented dairy product without plant sterols (control)Other: 1- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) per unit
- Registration Number
- NCT01571869
- Lead Sponsor
- Danone Research
- Brief Summary
The objective of this study is to compare efficacy of a plant sterol enriched yogurt given at different moments of the day in lowering blood cholesterol of hypercholesterolemic.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- male and post-menopausal female aged 40-80 years;
- BMI between 22 and 32 kg/m2,
- Non-smoker, Stabilized LDL-c over 3.0 mmol/L,
- Not taking any medication known to affect lipid metabolism for at least the previous 3 month period,
- Agree to follow the dietary recommendations in the context of their hypercholesterolemia,
- Have to give written consent to take part in the study
Exclusion Criteria
- Thyroid disease, diabetes mellitus, kidney disease or liver disease, Hypertension (95<SBP>140 mmHg and/or 45<DBP>90 mmHg),
- Previous history of symptomatic vascular disease, TG level > 2,8 g/l,
- History of metabolic or gastrointestinal disease with the exception of appendicectomy,
- Consumption of large amounts of alcohol,
- Having undergone general anesthesia in the month prior to pre-selection,
- Receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters,
- Having serious or acute disease likely to influence study results or involved in life time,
- Presenting allergy or hypersensitivity to milk proteins, or refusing to consume them,
- Refusing to stop his/her consumption of enriched plant sterol trade products during the study,
- In a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject,
- For female subjects: likely to change her hormonal substitutive treatment,
- Currently in an exclusion period following participation in another clinical trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description 2 = Control product 2- Low fat drinkable fermented dairy product without plant sterols (control) - 1 = Tested product 1- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) per unit -
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
McGill University
🇨🇦Ste-anne-de-bellevue, Quebec, Canada